Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek R Johnson

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Brain Pathology (Zurich, Switzerland)|December 18, 2024
Molecular profile of adult primary leptomeningeal gliomatosis aligns with glioblastoma, IDH-wildtypeYi Zhu, Darin D Carabenciov, Derek R Johnson, et al.
Neuro-Oncology Advances|February 27, 2023
Genomic markers of recurrence risk in atypical meningioma following gross total resectionRachael A Vaubel, Rahul Kumar, Taylor M Weiskittel, et al.
Cancer Treatment Reviews|April 16, 2025
Current and future directions in theranostics for neuroendocrine prostate cancerGokce Belge Bilgin, Fabrice Lucien-Matteoni, Aadel A Chaudhuri, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 25, 2025
2024 Alzheimer's Association criteria for Alzheimer's disease diagnosis are usually anchored to both plaques and tangles, not Aβ aloneClifford R Jack, David S Knopman, Heather J Wiste, et al.
Journal of Neuropathology and Experimental Neurology|August 7, 2021
Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway ActivationCristiane M Ida, Derek R Johnson, Asha A Nair, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2025
[<sup>177</sup>Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastasesGokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
Brain : a Journal of Neurology|September 20, 2025
Staging Alzheimer's disease through amyloid and tau PETDerek R Johnson, Heather J Wiste, Val Lowe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisBaayla D C Boon, Yoav D Piura, Christina M Moloney, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2026
Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic changeBrian J Burkett, Heather J Wiste, Derek R Johnson, et al.
Journal of Neuro-Oncology|March 6, 2025
Characterizing the molecular and spatial heterogeneity of midline gliomas in adults: a single institution analysisBryan J Neth, Robert M Kraft, Kathryn L Eschbacher, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Brain Pathology (Zurich, Switzerland)|December 18, 2024
Molecular profile of adult primary leptomeningeal gliomatosis aligns with glioblastoma, IDH-wildtypeYi Zhu, Darin D Carabenciov, Derek R Johnson, et al.
Neuro-Oncology Advances|February 27, 2023
Genomic markers of recurrence risk in atypical meningioma following gross total resectionRachael A Vaubel, Rahul Kumar, Taylor M Weiskittel, et al.
Cancer Treatment Reviews|April 16, 2025
Current and future directions in theranostics for neuroendocrine prostate cancerGokce Belge Bilgin, Fabrice Lucien-Matteoni, Aadel A Chaudhuri, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 25, 2025
2024 Alzheimer's Association criteria for Alzheimer's disease diagnosis are usually anchored to both plaques and tangles, not Aβ aloneClifford R Jack, David S Knopman, Heather J Wiste, et al.
Journal of Neuropathology and Experimental Neurology|August 7, 2021
Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway ActivationCristiane M Ida, Derek R Johnson, Asha A Nair, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 21, 2025
[<sup>177</sup>Lu] Lu-PSMA-617 treatment for metastatic castration-resistant prostate cancer (mCRPC) with cerebral and cerebellar metastasesGokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
Brain : a Journal of Neurology|September 20, 2025
Staging Alzheimer's disease through amyloid and tau PETDerek R Johnson, Heather J Wiste, Val Lowe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisBaayla D C Boon, Yoav D Piura, Christina M Moloney, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 7, 2026
Abnormal amyloid PET usually represents intermediate/high Alzheimer's disease neuropathologic changeBrian J Burkett, Heather J Wiste, Derek R Johnson, et al.
Journal of Neuro-Oncology|March 6, 2025
Characterizing the molecular and spatial heterogeneity of midline gliomas in adults: a single institution analysisBryan J Neth, Robert M Kraft, Kathryn L Eschbacher, et al.
Pageof 15